MicroBioTest   Report issue

For profit Phase 3 Phase 4
Founded: Sterling VA United States (1986)
Status: Acquired by Microbac (2009)

Organization Overview

First Clinical Trial
2011
NCT01314703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Microbiotest | MICROBIOTEST | MicroBioTest, Division of Microbac Laboratories, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

chlorhexidine (hibitane) (6 trials)

isopropyl alcohol (4 trials)

Drugs in Phase 3 Trials (2)

iodine povacrylex (DuraPrep Surgical) (2 trials)

sodium chloride (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Surgical Wound Infection (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 4